. . . . . "S&T TWOC Project - version 4" . "S&T TWOC version 3" . "2"^^ . "2023-07-20T09:47:15.990975"^^ . . . "for COVID-19 therapy" . "(319, 330)" . "considered" . "498" . "other antibiotics like azithromycin , ivermectin , eravacycline , valrubicin , streptomycin , nitazoxanide , teicoplanin , caspofungin , and colistin ; and other agents like hydroxychloroquine , chloroquine , tocilizumab , camostat , nafamostat , carfilzomib , interferon , aprepitant , and dexamethasone" . "(319, 330)" . "Results Repurposing of drugs from different pharmacological groups including antivirals like remdesivir, lopinavir, ritonavir, arbidol, oseltamivir, penciclovir, favipiravir, ganciclovir, and ribavirin; other antibiotics like azithromycin, ivermectin, eravacycline, valrubicin, streptomycin, nitazoxanide, teicoplanin, caspofungin, and colistin; and other agents like hydroxychloroquine, chloroquine, tocilizumab, camostat, nafamostat, carfilzomib, interferon, aprepitant, and dexamethasone can be considered for COVID-19 therapy." . "8j41d0a3" . "8j41d0a3-TRIPLE-ABSTRACT-2" . "caspofungin" . "therapy" . "RSA" . "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" . "eLtOIwfYxtvJfs35gRzMELNXy7Z6AwV7Is6D/3WKgJo0+zVaSuIKKJPz5zPY2bfdkitynbWVqv0JI6RdVVPOGDijCIVtlFOmtlE6aw9b/9BFmZuKVFy4oHfqcGO1xoI6pvOmuVmsHsKQi092GyLcEbQLNsN84p1gUCoQ48/vBKKNDxJ6vqQlUpFJRNMygHLbAZ3Y1jMS4/SBWPt4HBtdyCUMafj8NnCEKqTFt5zJZx4m6+pJwvOEUxUgDU90ZZLBVkqYB9K7Ne390mmC1NEwp5QQSVavTM7sWGouCuPiuih3TeLql7J4o4fVuHgqjIVeyDu0co+YpMOtR638Jtwp1e+dpjCH47dqySp7JOiCyVnNoQJZu8SkknBRgVtTcmurB9IAw8MoknXaoW/mFKow4Mr55VoaKHCv1L/bju+R2S+Pw3N5BVTKgMfh3Hym6R1Td06l7fcb2heP5+dIURJL8ksHlAA7JWQSIPNl3xlGiFoKxTAZ9zPW7ntjCEwAAAqc" . . .